News » Dispensary guidance news, England, Pharmacy Owners' News » Four products given Special Container status
May 29th 2025
Community Pharmacy England has advised that four products will be classified as special containers from June 1, 2025.
The four products are:
|
Generic drug name (dm+d descriptor) |
Brand and/or Manufacturer |
Pack size |
Special container |
|
Carmellose 1% eye drops 0.4ml unit dose preservative free |
Celluvisc® 1% eye drops 0.4ml unit dose (AbbVie Ltd) |
30 unit dose (3 x 10) |
Sub-pack of 10 |
|
Diclofenac 0.1% eye drops 0.3ml unit dose preservative free |
Voltarol® Ophtha (Thea Pharmaceuticals) |
40 unit dose (8 x 5) |
Sub-pack of 5 |
|
Netilmicin 3mg/ml / Dexamethasone 1mg/ml eye drops 0.3ml unit dose preservative free |
Netildex® (Nordic Pharma Ltd) |
20 unit dose (4 x 5) |
Sub-pack of 5 |
|
Terbutaline 5mg/2ml nebuliser liquid unit dose vials |
Bricanyl® Respules® (AstraZeneca UK Ltd) |
30 unit dose (4 x 5) |
Sub-pack of 5 |
These changes to special container status of products is in accordance with the special container criteria outlined in Part II Clause 10B of the Drug Tariff and the Original Pack Dispensing (OPD) exceptions outlined in the Human Medicines Regulations (HMR). The three HMR exceptions include:
